NY S06851

Creates the "Collaborative Practice Medication Adherence Act" allowing licensed physicians to voluntarily establish written protocols with qualified pharmacists to manage medication adherence for patients with chronic diseases

Defines "qualified pharmacist" as one with an unrestricted license, minimum two years of patient care experience within the last five years, and demonstrated competency in medication adherence through accredited programs

Permits qualified pharmacists under these protocols to adjust drug strength, frequency, or route of administration; order disease-related laboratory tests; perform routine patient monitoring including vital signs; and access patient medical records

Requires written patient consent for participation in collaborative practice medication adherence services, with patients able to discontinue at any time; pharmacists cannot delegate these services to other pharmacy personnel

Makes permanent the provisions of Chapter 21 of the Laws of 2011 authorizing collaborative drug therapy management between pharmacists and physicians, removing the July 1, 2026 expiration date